Verwendung: Dieses Produkt ist ausschließlich für Forschungszwecke bestimmt.
Alle Produktinformationen auf dieser Website dienen ausschließlich Bildungszwecken. Jede Form der Einbringung in den Körper von Menschen oder Tieren ist gesetzlich streng verboten. Dieses Produkt darf nur von zugelassenen und qualifizierten Fachleuten gehandhabt werden. Es ist kein Arzneimittel, Lebensmittel oder Kosmetikum und darf nicht als solches gekennzeichnet, verwendet oder falsch etikettiert werden.
KPV (Lysine-Proline-Valine) 250mcg/60caps
Während der Umstellung unserer Verpackung erhalten Sie möglicherweise Produkte mit dem bisherigen oder dem neuen Etikett. Formulierung, Reinheit und Qualität bleiben nach unseren Standards genau gleich.
- Kreditkarte
- Banküberweisung (SEPA Echtzeit)
- Banküberweisung (ACH)
- Wise
- Revolut
- Zelle
- Remitly
- Western Union
- Chime
- Andere
-25% auf alles – bis 31. Oktober
25% auf reguläre Preise statt anderer Angebote. Nur mit dem Krypto-Zahlungsrabatt kombinierbar.
Jede Charge wird auf Reinheit, Wirksamkeit und Qualität geprüft.
Laborergebnisse ansehen →KPV (Lysine-Proline-Valine) is the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH), corresponding to residues 11-13 and also present within the corresponding region of adrenocorticotropic hormone (ACTH).
Research interest centers on KPV's reported melanocortin receptor-independent activity in cell-based inflammatory signalling models, distinguishing it from full-length melanocortin receptor agonists. Research applications include melanocortin fragment structure-activity studies, NF-κB pathway investigation, and tripeptide stability/delivery research.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
3D Molecular Structure
Drag to rotate · scroll to zoom| Chemical Formula | C16H30N4O4 |
|---|---|
| Synonyms | Lys-pro-val, L-Valine, N-(1-L-lysyl-L-prolyl)-, Msh (11-13), L-Lysyl-L-prolyl-L-valine, Lysyl-prolyl-valine, ACTH-(11-13) |
| Molar Mass | 342.43 g/mol |
| CAS Number | 67727-97-3 |
| PubChem CID | 125672 |
| Total Compound Content | 15mg (250mcg/capsule) |
| Shelf Life | 36 months |
Results refer to the tested sample. Check the batch and date in the report.
How does KPV's proposed mechanism differ from full-length alpha-MSH's melanocortin receptor activity?
Full-length alpha-MSH activates the canonical melanocortin receptors (primarily MC1R), a G protein-coupled receptor pathway producing cAMP-dependent downstream signalling.
KPV, as a minimal C-terminal tripeptide fragment, is investigated for effects in cell-based models (including NF-κB transcriptional readouts) that appear to occur with reduced dependence on classical MC1R-mediated signalling, making it a research tool for distinguishing melanocortin receptor-dependent from receptor-independent peptide activity.
Researchers studying this distinction typically use MC1R antagonists or receptor-knockout/knockdown models alongside KPV exposure to determine the receptor-dependence of observed effects.
What cell-based assays are used to study KPV's effects on NF-κB signaling?
Standard approaches include NF-κB-responsive luciferase reporter assays in cell lines stimulated with a pro-inflammatory trigger (such as LPS or TNF-α) with and without KPV co-treatment, alongside direct measurement of NF-κB nuclear translocation by immunofluorescence or Western blot of nuclear/cytoplasmic fractions. Downstream readouts often include quantification of NF-κB target gene products (pro-inflammatory cytokines, chemokines) by ELISA or qPCR to characterise the functional consequence of any observed transcriptional modulation.
Why is KPV used as a tool for studying the shared C-terminal sequence of alpha-MSH and ACTH?
Because the Lys-Pro-Val sequence is conserved in both alpha-MSH and ACTH at the same relative position, KPV serves as a minimal structural probe for research questions about which biological activities of these larger peptide hormones map to this specific C-terminal motif versus other regions of the parent sequence. Comparative studies using KPV alongside other fragments of alpha-MSH/ACTH (such as the N-terminal or central regions) allow researchers to build structure-activity maps of the full hormone sequence.
